Table 1.
No. (%) | ||
---|---|---|
Sex | Male | 33 (78%) |
Female | 9 (21%) | |
Age | Median | 66 |
Range | 37–86 | |
Tumor site | Glottic/subglottic | 17 (40%) |
Supraglottic | 16 (38%) | |
Hypopharyngeal | 5 (12%) | |
Unknown primary (function) | 2 (5%) | |
Thyroid | 2 (5%) | |
T classification | 0–2 | 5 (12%) |
3–4 | 20 (48%) | |
Recurrent | 15 (36%) | |
Unknown or N/A | 2 (5%) | |
N classification | N0 | 10 (24%) |
N+ | 15 (36%) | |
Recurrent | 15 (36%) | |
Unknown or N/A | 2 (5%) | |
Surgical procedure | TL | 35 (81%) |
TL + PP | 4 (10%) | |
TLP | 4 (10%) | |
Reconstruction | None | 32 (76%) |
Pectoralis | 2 (5%) | |
ALT (patch) | 3 (7%) | |
ALT (tubed) | 2 (5%) | |
Jejunal | 2 (5%) | |
Radiation | None | 5 (12%) |
Pre-operative RT | 11 (26%) | |
Pre-operative chemoRT | 6 (14%) | |
Post-operative RT | 12 (29%) | |
Post-operative chemoRT | 6 (14%) | |
Timing of TEP | Primary | 22 (53%) |
Secondary | 17 (40%) | |
Both | 3 (7%) | |
TOTAL | 42 |